From Name:
From Email:
To Name:
To Email:

Optional Message:

New technology promises to kill resistant bacteria

from The Bay Citizen

In 2003, after selling South San Francisco-based Eos Biotechnology for a little more than $37 million, Dave Martin, a biochemist, started looking around the academic world for novel ideas. He found an intriguing concept in Jeffrey F. Miller's University of California, Los Angeles lab, which was looking at defense mechanisms that certain bacteria use naturally to fight off other bugs. With some seed money from his own pocket and from friends and family, Martin rolled up his sleeves to see if he and his collaborators could engineer what are known as R-type pyocins (now branded by the company as Avidocins) that could mimic this natural phenomenon. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063